Business Description
Innovation Pharmaceuticals Inc
NAICS : 325414
SIC : 2834
ISIN : US45782D1000
Description
Innovation Pharmaceuticals Inc is a clinical-stage pharmaceutical company in the United States. It is engaged in developing therapies with oncology, dermatology, and antimicrobial applications. Its clinical trials focus on evaluating its drug candidates, including Kevetrin for the treatment of cancers; Brilacidin, a potential therapeutic for the treatment of the novel coronavirus. The company focuses on developing small molecule therapies to treat diseases in the areas of cancer, antibiotics, and inflammatory disease.
Financial Strength
| Name | Current | Vs Industry | Vs History |
|---|
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 47.65 | |||||
9-Day RSI | 47.97 | |||||
14-Day RSI | 48.15 | |||||
3-1 Month Momentum % | -57.14 | |||||
6-1 Month Momentum % | -70 | |||||
12-1 Month Momentum % | 200 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History |
|---|
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History |
|---|
Profitability Rank
| Name | Current | Vs Industry | Vs History |
|---|
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
EV-to-EBIT | 0.08 | |||||
EV-to-EBITDA | 0.1 | |||||
EV-to-FCF | 0.1 | |||||
Earnings Yield (Greenblatt) % | 1250 | |||||
FCF Yield % | -1322.58 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:IPIX
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Innovation Pharmaceuticals Inc Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -0.009 | ||
| Beta | 67.0641 | ||
| 3-Year Sharpe Ratio | 0.71 | ||
| 3-Year Sortino Ratio | 2.5 | ||
| Volatility % | 655.88 | ||
| 14-Day RSI | 48.15 | ||
| 14-Day ATR ($) | 0.000624 | ||
| 20-Day SMA ($) | 0.000315 | ||
| 12-1 Month Momentum % | 200 | ||
| 52-Week Range ($) | 0.00001 - 0.05 | ||
| Shares Outstanding (Mil) | 518.35 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 0 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Innovation Pharmaceuticals Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Innovation Pharmaceuticals Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| First quarter earnings results for 2027 | 2026-12-21 | In 179 days | ||
| General meeting for 2026 | 2026-09-24 | In 91 days | ||
| Annual report for 2026 | 2026-09-17 | In 84 days | ||
| Third quarter earnings results for 2025 | 2026-06-29 | In 4 days |
Show
Entries
Innovation Pharmaceuticals Inc Frequently Asked Questions
What is Innovation Pharmaceuticals Inc(IPIX)'s stock price today?
The current price of IPIX is $0.00. The 52 week high of IPIX is $0.05 and 52 week low is $0.00.
When is next earnings date of Innovation Pharmaceuticals Inc(IPIX)?
The next earnings date of Innovation Pharmaceuticals Inc(IPIX) is 2026-06-29 Est..
Does Innovation Pharmaceuticals Inc(IPIX) pay dividends? If so, how much?
Innovation Pharmaceuticals Inc(IPIX) does not pay dividend.
Guru Commentaries on OTCPK:IPIX
No articles.
Press Release
Articles on Innovation Pharmaceuticals Inc
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers